SCHEMBL30980495

SCHEMBL30980495

CC(C)(C)OC(=O)CCOCCOCCOCCOCCC(=O)O

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TLR2 O60603 2/20 0.34
TLR1 Q15399 2/20 0.34
STING1 Q86WV6 1/20 0.34
TSHR P16473 1/20 0.33
HDAC3 O15379 2/20 0.33
HDAC1 Q13547 2/20 0.33
HDAC2 Q92769 2/20 0.33
HDAC8 Q9BY41 2/20 0.33
PLA2G4B P0C869 1/20 0.33
HDAC6 Q9UBN7 1/20 0.33
EGLN1 Q9GZT9 2/20 0.32
BLM P54132 1/20 0.32
PMP22 Q01453 1/20 0.32
HSD17B10 Q99714 1/20 0.32
ALDH1A1 P00352 1/20 0.32
KDM6B O15054 1/20 0.32
KDM5C P41229 1/20 0.32
PHF8 Q9UPP1 1/20 0.32
KDM2A Q9Y2K7 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12092180 1.00 TLR2 (0.34) TLR2TLR1STING1TSHRHDAC3
SCHEMBL26292093 1.00 TLR2 (0.34) TLR2TLR1STING1TSHRHDAC3
SCHEMBL7677587 1.00 TLR2 (0.34) TLR2TLR1STING1TSHRHDAC3
SCHEMBL22717025 1.00 TLR2 (0.34) TLR2TLR1STING1TSHRHDAC3
SCHEMBL7676443 1.00 TLR2 (0.34) TLR2TLR1STING1TSHRHDAC3
SCHEMBL19475654 1.00 TLR2 (0.34) TLR2TLR1STING1TSHRHDAC3
SCHEMBL31395742 1.00 TLR2 (0.34) TLR2TLR1STING1TSHRHDAC3
SCHEMBL20552587 0.98 STING1 (0.35) TLR2TLR1STING1TSHRHDAC3
SCHEMBL27410618 0.93 ALDH1A1 (0.40) TLR2TLR1TSHRHDAC1HDAC2
SCHEMBL5735427 0.92 STING1 (0.37) TLR2TLR1STING1TSHRHDAC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4651902-A2 ASGPR BINDING COMPOUNDS AND CONJUGATES Lycia Therapeutics, Inc. (US) 2025-11-26 EP disclosed
WO-2024155747-A2 ASGPR BINDING COMPOUNDS AND CONJUGATES LYCIA THERAPEUTICS, INC. (US) 2024-07-25 WO disclosed